Results 21 to 30 of about 36,842 (245)
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease [PDF]
, 2014 Febuxostat is a nonpurine xanthine oxidase (XO) inhibitor, which recently received marketing approval. However, information regarding the experience with this agent among advanced chronic kidney disease (CKD) patients is limited. In the current study, we
Daisuke Nagata +7 more
core +1 more source
BMJ Open, 2019 Objectives Hyperuricemia and obesity both play a role in the development of hypertension. However, limited evidence is available for the combined effect of hyperuricemia and obesity on the prevalence of hypertension in the Chinese population. We aimed to
Simiao Tian +3 more
doaj +1 more source
Hyperuricemia and non-dipping blood pressure [PDF]
, 2013 Oreste Marrone,1 Maria Rosaria Bonsignore1,21National Research Council, Institute of Biomedicine and Molecular Immunology, Palermo, Italy; 2Biomedical Department of Internal and Specialistic Medicine, University of Palermo, Palermo, ItalyThe strong ...
Marrone, O +3 more
core +1 more source
Influence of occupational exposure on hyperuricemia in steelworkers: a nested case–control study
BMC Public Health, 2022 Background Occupational exposure may be associated with an increased risk of developing hyperuricemia. This study sheds lights on the association between occupational exposure and hyperuricemia in steelworkers.
Yuanyu Chen +8 more
doaj +1 more source
The treatment of hyperuricemia [PDF]
International Journal of Cardiology, 2016 Hyperuricemia has long been established as the major etiologic factor in gout. Alongside with an inflammatory state triggered by urate crystal deposition in the joints, hyperuricemia displayed additional pathophysiological consequences leading to tissue inflammation mainly in the vascular wall.
Gliozzi, Micaela +3 more
openaire +3 more sources
Research progress on treatment of hyperuricemia [PDF]
, 2021 Hyperuricemia is a metabolic disease caused by a disorder of purine metabolism. The prevalence of hyperuricemia is about 13.3% in Chinese adults. Hyperuricemia is not only the most important risk factor for gout, but also closely associated with target ...
Qin Xianhui +3 more
core +1 more source
Kidney & Blood Pressure Research, 2018 Background/Aims: The aim of the study was to investigate clinicopathological characteristics, the role of immunosuppressive therapy and renal outcome in IgA nephropathy (IgAN) patients with hyperuricemia.
Yiping Ruan +8 more
doaj +1 more source
Journal of Translational Medicine, 2020 Background Hypertension and high triglyceride are two of the most important risk factors for hyperuricemia. Epidemiological records show that hypertension and dyslipidemia often coexist and may significantly increase the risk of target organ damage ...
Yuan Zhang +8 more
doaj +1 more source
Experimental Biology and Medicine, 1965 Recent epidemiologic studies have revealed a striking correlation between obesity and hyperuricemia (1,2). This propensity of the obese is accentuated by starvation2. Previous reports implicate a decrease in renal clearance of uric acid, but the mechanism of this decline has not been clarified(345).
M H, ALDERMAN, R P, DAVIS
openaire +2 more sources
Effect of Intestinal Flora on Hyperuricemia-Induced Chronic Kidney Injury in Type 2 Diabetic Patients and the Therapeutic Mechanism of New Anti-Diabetic Prescription Medications [PDF]
, 2023 Wei Yan,1,2 Song Wen,1 Ligang Zhou1,3 1Department of Endocrinology, Shanghai Pudong Hospital, n University, Shanghai, 201399, People’s Republic of China; 2Department of General Practice, Jinshan Hospital, Fudan University, Shanghai, 201508, People’s ...
Zhou L, Wen S, Yan W
core